Financial Management Professionals’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$432 Buy
+5
New +$438 ﹤0.01% 973
2025
Q2
Sell
-4
Closed -$453 1086
2025
Q1
$453 Hold
4
﹤0.01% 896
2024
Q4
$423 Hold
4
﹤0.01% 903
2024
Q3
$0 Hold
4
﹤0.01% 1059
2024
Q2
$0 Sell
4
-48
-92% -$5.66K ﹤0.01% 1041
2024
Q1
$7K Sell
52
-9
-15% -$1.12K ﹤0.01% 610
2023
Q4
$7K Buy
61
+5
+9% +$558 ﹤0.01% 620
2023
Q3
$6K Sell
56
-10
-15% -$1.27K ﹤0.01% 586
2023
Q2
$10K Buy
66
+10
+18% +$1.36K ﹤0.01% 545
2023
Q1
$7K Buy
56
+19
+51% +$2.38K ﹤0.01% 635
2022
Q4
$5K Sell
37
-33
-47% -$3.83K ﹤0.01% 640
2022
Q3
$7K Buy
70
+66
+1,650% +$7.24K ﹤0.01% 558
2022
Q2
$0 Buy
+4
New +$475 ﹤0.01% 1160

Other funds holding ZBH

Financial Management Professionals's ZBH Position: Q2 2026 in Review

Financial Management Professionals opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 5 shares worth $432. The stake represents ﹤0.01% of the portfolio and ranks #973 among its holdings. This is a return to the name: Financial Management Professionals previously reported a position in ZBH as recently as Q1 2025.

Financial Management Professionals first reported a position in ZBH in Q2 2022 and has held it in 13 quarters since. The position peaked at $10K in Q2 2023. 111 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Financial Management Professionals held 5 shares of Zimmer Biomet worth $432 as of Q2 2026.
  • Zimmer Biomet was a new Financial Management Professionals position in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #973 holding.
  • Financial Management Professionals first reported a position in Zimmer Biomet in Q2 2022 and has held it in 13 quarters since.
  • Financial Management Professionals's Zimmer Biomet position peaked at $10K in Q2 2023.
  • 111 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.